Anna Maria D'URSI | Progetti

CONSULENZA ANALITICO/SCIENTIFICA SIU SOSTANZE DI INTERESSE FARMACEUTICO DI NATURA PEPTIDICA

Mesenchymal stem cells (MSCs) are endowed with huge regenerating potential. [3, 4] According to the International Society for Cellular Therapy (ISCT), they must show adherence to plastic in standard culture conditions. They have to express specific surface markers (= 95%), that are CD105, CD73 and CD90 and at the same time they must lack expression (= 2%) of CD45, CD34, CD14 or CD11b, CD79a or CD1

Studio analitico/scientifico per la caratterizzazione di sostanze di interesse farmaceutico di natura peptidica

In the perspective of a theranostic application, the present project is focused on the identification of new substances able to detect Aß peptide at minimal concentration, to be used for early AD diagnosis and to control the formation of ß amyloid fibrils to be used in AD therapy.The project will be developed according to the following points:Identification of Aß-interacting molecules starting

Caratterizzazione del prodotto Salmon Calcitonin attraverso la tecnologia NMR - NMR Characterization of Salmon Calcitonin

Objective of the present project is the design of moleules able to catch potential neurodegenerative biomarkers. Ultimately, these will be used to functionalize ultra¿small Magnetic Nanoparticles (MNPs) for the early and ultrasensitive realization of a diagnostic device based on magnetoresistive sensors, microfluidic device,

Fondi di Finanziamento Attività Base Ricerca 2017 art. 1 commi 295 e ss. , L. 11 Dicembre 2016 n. 232

ESECUZIONE DI ATTIVITA' DI RICERCA " SUPPORTO ANALITICO/SCIENTIFCO SU SOSTANZE DI INTERESSE FARMACEUTICO" - RESP. D'URSI